Evidence map›Paper›PMID 39931528›Full record

ArticleInternational journal of nanomedicine2025

CircPRMT5, a Potential Salivary Biomarker, Facilitates the Progression of Head and Neck Squamous Cell Carcinoma via the IGF2BP3-SERPINE1 Pathway.

Siqi Jiang, Linlin Ou, Yueqi Wang, Kai Su, Zhipei Chen, Lihong He, Xun Xu, Bin Cheng, Juan Xia, Zhaona Fan

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Mechanism of action ofOncology letters · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Siqi JiangHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Linlin OuHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Yueqi WangHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Kai SuHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Zhipei ChenHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Lihong HeHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Xun XuHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Bin ChengHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Juan XiaHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.
Zhaona FanHospital of Stomatology, Sun Yat-sen University, Guangzhou, People's Republic of China.ORCID 0009-0009-1887-2708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Circular RNAs (circRNAs) are associated with the progression of tumors and hold promise as potential biomarkers for liquid biopsy. Among these, the role of circPRMT5 in head and neck squamous cell carcinoma (HNSCC) remains to be elucidated. This study aims to examine the role and underlying mechanisms of circPRMT5 in the progression of HNSCC and to assess its potential diagnostic value in saliva exosomes. Methods: The expression of circPRMT5 and its clinical significance in HNSCC were investigated. Both in vitro and in vivo studies were performed to elucidate the biological role of circPRMT5 in HNSCC. RNA sequencing was utilized to identify downstream mechanisms. To evaluate and validate these mechanisms, Western blotting, RNA-FISH, immunofluorescence, immunohistochemistry, RIP, and rescue experiments were employed. Finally, salivary exosomes were isolated, and the expression levels of circPRMT5 were assessed using qRT-PCR. Results: The upregulation of circPRMT5 in HNSCC tissues was identified to be correlated with cervical lymph node metastasis and advanced clinical T stage. Both in vitro and in vivo experiments manifested that circPRMT5 promoted the proliferation and metastasis of HNSCC. Mechanistically, circPRMT5 was demonstrated to directly bind to and stabilize the insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), which, subsequently, binds to and stabilizes the serpin family E member 1 (SERPINE1) mRNA, thereby enhancing SERPINE1 expression. Furthermore, rescue experiments indicated that the proliferative, invasive, and migratory effects of circPRMT5 in HNSCC were dependent on the involvement of IGF2BP3 and SERPINE1. Notably, circPRMT5 levels were significantly elevated in the saliva exosomes of HNSCC patients, exhibiting substantial diagnostic value. Conclusion: CircPRMT5 exhibits significant diagnostic utility through salivary exosomes and plays a crucial role in promoting the progression of HNSCC via the IGF2BP3-SERPINE1 pathway. These findings highlight the potential of circPRMT5 as a noninvasive diagnostic biomarker and a therapeutic target for patients with HNSCC.

Indexed as

Biomarkers, TumorHead and Neck NeoplasmsPlasminogen Activator Inhibitor 1RNA-Binding ProteinsRNA, CircularSquamous Cell Carcinoma of Head and NeckAnimalsCell Line, TumorCell ProliferationDisease ProgressionExosomesFemaleGene Expression Regulation, NeoplasticHumansMaleMiceBiomarkers, TumorPlasminogen Activator Inhibitor 1PRMT5 protein, humanProtein-Arginine N-MethyltransferasesRNA-Binding ProteinsRNA, CircularSERPINE1 protein, humancircPRMT5head and neck cancerIGF2BP3salivary exosomesSERPINE1

Identifiers

PMID39931528
PMCPMC11807777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.